Recent news from 24dunia
   

Search results for  

cipla drug price list 

 ( 1-10 )
Sort by: Relevance |   Date
 

National Pharmaceutical Pricing Authority moves to bring cancer drugs under price control

Sets July 24 deadline for six pharma firms to submit pricing data of their cancer drugs, pulls them up for dithering to furnish pricing dataThe National Pharmaceutical Pricing Authority (NPPA) is moving fast on reducing prices of cancer drugs. It has pulled up six pharma companies, including Ranbaxy, Biocon, Cipla and Pfizer, for not providing pricing data of cancer drugs sold by them.NPPA required...
Source : DNA |
Category : National | City : Ahmedabad

Regulator to chase drug cos on overcharging

Drug-price regulator, National Pharmaceutical Pricing Authority (NPPA) is set to chase drug majors for defaulting on penalties imposed for overcharging consumers. The defaulters include Cipla Healthcare, Lupin Limited, Dr. Reddy’s, Cadila and Baxter Pharmaceuticals among many others.NPPA has issued a list of 1,018 cases, since its inception in 1997 up to March 2014, demandingNPPA has now decided to...
Source : Hindustan Times |
Category : Business | City : Delhi

Cipla invests in Chase to fight Alzheimer’s

Cipla and a group of investors have invested around $21 million in US-based Chase Pharmaceuticals Corporation, which develops drug molecules to fight Alzheimer’s disease.The investment will support two rounds of clinical trials of Chase’s lead drug CPC 201.A press statement from Cipla said the company would also collaborate with Chase to develop the drug.Cipla, therefore, could be in a position to...
Source : Telegraphindia |
Category : Business | City : Mon

Cipla board approves retirement of M K Hamied

Drug firm Cipla Ltd on Thursday approved the retirement of executive vice chairman M K Hamied with effect from March 31,...
Source : Ndtv |
Category : Others

Cipla to acquire 14.6% stake in Chase Pharma of US

Drugmaker Cipla on Monday said it will acquire 14.6% stake in US-based Chase Pharmaceuticals Corporation Inc for $1.5 million through its wholly owned subsidiary Cipla (EU), UK.Chase, based in Washington DC, is an early-stage drug development company focused on developing new approaches for treating Alzheimer's disease.The Indian drug maker's investment, through Cipla New Ventures, is part of a syndicate...
Source : DNA |
Category : National

Cipla inks pact with Merck

Cipla has entered into an agreement with MSD to market the latter’s anti-HIV drug raltegravir in the country.This is the first time that Cipla is entering into a strategic partnership with a multinational drug company. MSD is the trade name of Merck & Co., Inc.Under the India-specific arrangement, Cipla will have a non-exclusive licence to market, promote and distribute MSD’s raltegravir 400mg tablet...
Source : Telegraphindia |
Category : Business | City : Mon

Is Cipla ripe for a $10 billion MNC takeover?

Cipla Ltd, India's fourth-largest drug maker, on Wednesday categorically denied talk that it is next in line for a multi-billion dollar takeover bid.The company's stock price spurted on Wednesday on reports that multinational pharma companies might be interested in it.Mumbai-based Cipla is rumoured to be in talks with multinational companies, including Teva Pharmaceutical Industries. Other names that...
Source : DNA |
Category : National

Cipla to launch biosimilar anaemia drug via Hetero deal

Cipla said Actorise is available in the pre-filled syringes (PFS) in the strengths of 25 mcg and 40 mcg priced at Rs 1,500 and Rs 2,200 respectively.today announced a collaboration with Hetero Drugs to launch a medication under the Actorise brand for treatment of anaemia caused due to chronic kidney disease."The collaboration stands as a multi-partner co- marketing deal which offers Cipla a license...
Source : Moneycontrol |
Category : Business

Drug price regulator runs into vanishing cos

India's drug price regulator has a unique problem. As it moves to revise the prices of medicines, it has found that the manufacturers of as many as 55 of them have simply gone missing."There is no information available for 55 random formulations and we may exclude them from the list of price fixation," CP Singh, chairman, Drug price watchdog National Phar maceutical Pricing Authority (NPPA) told HT.On...
Source : Yahoo Finance |
Category : Personal Finance | City : New Delhi

Govt mulls bringing cancer, AIDS drugs under price control

National Pharmaceutical Pricing Authority met recently to consider ways of bringing medicines, which are not covered by the list of essential drugs, under some regulatory ambit in order to check prices.NEW DELHI: Drug prices regulator NPPA is looking at bringing medicines used for treating diseases such as cancer, AIDS and malaria under the price control mechanism.The National Pharmaceutical Pricing...
Source : Times Of India |
Category : National
Related search